Abstract

To provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy in hospitalized patients; the guidelines are designed to promote optimization of patient clinical outcomes while minimizing the risks for potential anticoagulation-related errors and adverse events. The medical literature was reviewed using MEDLINE (1946-January 2013), EMBASE (1980-January 2013), and PubMed (1947-January 2013) for topics and key words including, but not limited to, standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting. Non-English-language publications were excluded. Specific MeSH terms used include algorithms, anticoagulants/administration and dosage/adverse effects/therapeutic use, clinical protocols/standards, decision support systems, drug monitoring/methods, humans, inpatients, efficiency/ organizational, outcome and process assessment (health care), patient care team/organization and administration, program development/standards, quality improvement/organization and administration, thrombosis/ drug therapy, thrombosis/prevention and control, risk assessment/standards, patient safety/standards, and risk management/methods. Because of this document's scope, the medical literature was searched using a variety of strategies. When possible, recommendations are supported by available evidence; however, because this paper deals with processes and systems of care, high-quality evidence (eg, controlled trials) is unavailable. In these cases, recommendations represent the consensus opinion of all authors and are endorsed by the Board of Directors of the Anticoagulation Forum, an organization dedicated to optimizing anticoagulation care. The board is composed of physicians, pharmacists, and nurses with demonstrated expertise and experience in the management of patients receiving anticoagulation therapy. Recommendations for delivering optimized inpatient anticoagulation therapy were developed collaboratively by the authors and are summarized in 8 key areas: (1) process, (2) accountability, (3) integration, (4) standards of practice, (5) provider education and competency, (6) patient education, (7) care transitions, and (8) outcomes. Recommendations are intended to inform the development of coordinated care systems containing elements with demonstrated benefit in improvement of anticoagulation therapy outcomes. Recommendations for delivering optimized inpatient anticoagulation therapy are intended to apply to all clinicians involved in the care of hospitalized patients receiving anticoagulation therapy. Anticoagulants are high-risk medications associated with a significant rate of medication errors among hospitalized patients. Several national organizations have introduced initiatives to reduce the likelihood of patient harm associated with the use of anticoagulants. Health care organizations are under increasing pressure to develop systems to ensure the safe and effective use of anticoagulants in the inpatient setting. This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients.

Highlights

  • An estimated 4 million patients in the United States and almost 7 million worldwide are taking chronic oral anticoagulants, primarily warfarin or other coumarin derivatives, for prevention and treatment of venous and arterial thromboembolism.[1,2] Hospitalized patients may be treated with anticoagulants for traditional ambulatory indications such as stroke prevention for atrial fibrillation, as well as for conditions encountered primarily in the inpatient setting, including venous thromboembolism (VTE) prophylaxis and treatment, and acute coronary syndrome (ACS)

  • Anticoagulants are high-risk medications associated with a significant rate of medication errors among hospitalized patients

  • Healthcare organizations are under increasing pressure to develop systems to assure the safe and effective use of anticoagulants in the inpatient setting

Read more

Summary

Introduction

An estimated 4 million patients in the United States and almost 7 million worldwide are taking chronic oral anticoagulants, primarily warfarin or other coumarin derivatives, for prevention and treatment of venous and arterial thromboembolism.[1,2] Hospitalized patients may be treated with anticoagulants for traditional ambulatory indications such as stroke prevention for atrial fibrillation, as well as for conditions encountered primarily in the inpatient setting, including venous thromboembolism (VTE) prophylaxis and treatment, and acute coronary syndrome (ACS). It is a companion document to our prior guidelines published as “Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum.”[12] the prior document suggested that its recommendations should “apply to all clinicians involved in the care of patients receiving anticoagulation, regardless of the structure and setting in which that care is delivered”, there are some anticoagulation-related challenges that are unique to the inpatient arena. These guidelines will discuss broad elements that need to be in place for effective management of anticoagulant therapy in hospitalized patients. Specific MeSH terms used for our search include: algorithms, anticoagulants/administration & dosage/adverse effects/ therapeutic use, clinical protocols/standards, decision support systems, drug monitoring/ methods, humans, inpatients, efficiency/organizational, outcome and process assessment (Health Care), patient care team/organization & administration, program development/ standards, quality improvement/organization & administration, thrombosis/drug therapy, thrombosis/prevention & control, risk assessment/standards, patient safety/standards, risk management/methods

Process
Accountability
Integration
Standards of Practice
Provider Education and Competency
Patient Education
Care Transitions
Outcomes
Findings
Summary

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.